Human parthenogenetic stem cell therapy improves experimental traumatic brain injury deficits Feb. 19, 2019
Otsuka Pharmaceutical initiates two phase III trials of centanafadine in adults with ADHD Feb. 19, 2019
Melittin-nanoparticles target liver sinusoidal endothelial cells and suppress liver metastasis Feb. 19, 2019
Afibromer shielded engineered allogeneic cells demonstrate safety and efficacy in hemophilia A model Feb. 19, 2019
RSS